Parameters group studied (n= 10) | Renal tissue homogenate | |||
SOD (U/g protein) | CAT (U/g) | GSH (µmol/g) | GSHPx (U/g) | |
Normal control gp. | 5.9bcd ± 0.2 | 1.9bcde ± 0.1 | 37.44bcd ±3.09 | 1.5bcde ± 0.05 |
Diabetic gp. | 4.21acde ± 0.3 | 1.0acde ± 0.07 | 29.8acde ± 1.08 | 0.9acde ± 0.02 |
Ischemic reperfused (IR) gp. | 3.6abde ± 0.1 | 0.9abde ± 0.08 | 24.67abde ± 2.31 | 0.7abde ± 0.02 |
Diabetic + I/R gp. | 2.9abce ± 0.2 | 0.4abce ±0.09 | 21.5acbe ± 1.7 | 0.4abce ± 0.02 |
Sitaglipten treated (Diabetic + I/R) gp. | 5.7bcd ± 0.3 | 1.8abcd ± 0.1 | 38.3abd ± 1.3 | 1.4abcd ± 0.04 |
F (p) | 316.985* (<0.001) | 513.959* (<0.001) | 135.937* (<0.001) | 2047.170* (<0.001) |
LSD (5%) | 0.208 | 0.080 | 1.817 | 0.028 |